Tag: Pfizer sickle cell treatment controversy
Pfizer Withdraws Oxbryta Sickle Cell Treatment from Global Markets
Pfizer, a leading pharmaceutical company, made headlines on Wednesday with the announcement that it would be withdrawing Oxbryta, a medication used to treat sickle cell disease, from all global markets. This decision was prompted...